How is Creutzfeldt Jacob disease diagnosed?

Information about diagnosis is currently limited for this condition.

Are there treatments for Creutzfeldt Jacob disease?

Information about treatment is currently limited for this condition.

What complications can arise from Creutzfeldt Jacob disease?

Creutzfeldt Jacob disease can lead to serious complications as it progresses. Patients may experience severe muscle weakness, poor vision, and difficulties with balance and coordination. Additionally, the disease can cause involuntary jerking movements known as myoclonus, which can further impact daily activities and overall quality of life.

How does Creutzfeldt Jacob disease affect daily life?

Living with Creutzfeldt Jacob disease can be very challenging. As the disease progresses, individuals may face difficulties with language, coordination, and even sleep patterns. These changes can make it hard to perform everyday tasks and may require assistance from family members or caregivers.

What is the prognosis for someone with Creutzfeldt Jacob disease?

The prognosis for Creutzfeldt Jacob disease is quite serious. It typically leads to death within about a year from the start of symptoms. This rapid progression means that the quality of life can be significantly affected as the disease advances, requiring support for both patients and their families.

Are there any specialists recommended for managing Creutzfeldt Jacob disease?

While specific specialist recommendations are not detailed, it is important for individuals with Creutzfeldt Jacob disease to work with healthcare providers who understand neurological disorders. Neurologists or specialists in brain diseases can help manage symptoms and provide support for both patients and their families during this difficult time.

Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Creutzfeldt Jacob disease (CJD) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

Creutzfeldt Jacob disease

MONDO:0005357

Also known as:CJDCJD (Creutzfeldt Jakob disease)Creutzfeldt Jakob Disease

Find Clinical TrialsTrials

Overview

A rare transmittable degenerative disorder of the brain caused by prions. Morphologically it is characterized by spongiform degeneration of the cerebral and cerebellar cortex. Signs and symptoms include sleep disturbances, personality changes, aphasia, ataxia, muscle atrophy and weakness, visual loss, and myoclonus. It usually leads to death within a year from the onset of the disease.

Clinical Trials7 registered · 4 recruiting

Clinical Presentation

Built from Human Phenotype Ontology (HPO) phenotype annotations and GeneReviews clinical descriptions. Features represent findings documented across known cases — not an exhaustive list of possible symptoms.

No HPO annotations are available for this condition.

GeneReviews

Clinical Guidance

Genetic prion disease generally manifests with cognitive difficulties, ataxia, and myoclonus (abrupt jerking movements of muscle groups and/or entire limbs). The order of appearance and/or predominance of these features and other associated neurologic and psychiatric findings vary. The three major phenotypes of genetic prion disease are genetic Creutzfeldt-Jakob disease (gCJD), fatal familial insomnia (FFI), and Gerstmann-Strussler-Scheinker (GSS) syndrome. Although these phenotypes display overlapping clinical and pathologic features, recognition of these phenotypes can be useful when providing affected individuals and their families with information about the expected clinical course. The age at onset typically ranges from ages 50 to 60 years. The disease course ranges from a few months in gCJD and FFI to a few (up to 4, and in rare cases up to 10) years in GSS syndrome. provides information on the frequency of neurologic features in the most frequent genetic prion disease phenotypes that emerge during the disease course. While some PRNP pathogenic variants are associated with specific neuropathologic phenotypes, individuals in the same family who are heterozygous for the same PRNP variant may develop distinct clinicopathologic phenotypes . Table 2. Select Features of Genetic Prion Disease by Phenotype and PRNP Pathogenic Variant Feature | % of Persons w/Feature by Phenotype PRNP Variant

Diagnosis

Drawn from GeneReviews diagnostic guidelines, newborn screening panel status (RUSP), and ClinGen gene-disease validity classifications. Reflects current clinical evidence and consensus where available.

GeneReviews

Diagnostic Criteria

Suggestive Findings

Genetic prion disease should be suspected in individuals with the following clinical, laboratory, and imaging findings and family history.

Clinical

Genetic prion disease is a progressive neurodegenerative syndrome with rapid evolution of clinical signs (which reflect involvement of various neuroanatomic structures) – typically, dementia in combination with the following developing within a few months or (rarely) a few years:

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

No approved treatments are currently available for Creutzfeldt Jacob disease. The disease remains an area of unmet medical need.

GeneReviews

Management Guidelines

Evaluations Following Initial Diagnosis

To establish the extent of disease and needs in an individual diagnosed with genetic prion disease, the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended. Because of very rapid disease progression and short survival time after the diagnosis, evaluations for supportive care must be performed early. They include the following:

Prognosis

Based on GeneReviews surveillance recommendations, HPO phenotype frequency and severity annotations, and published prevalence estimates from Orphanet and OMIM.

GeneReviews

Surveillance Guidelines

Because of very rapid disease progression, close periodic monitoring by the multidisciplinary team is needed, typically every 14 days to evaluate need for treatment of symptoms.

Source: GeneReviews — "Genetic Prion Disease"

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

7 clinical trials registered, 4 recruiting. Interventions under study include other interventions and drug therapy. Pipeline includes 1 PHASE3, 1 PHASE1, 1 NA. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT06539169](https://clinicaltrials.gov/study/NCT06539169)

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:07 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 7 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

FAQ

Frequently Asked Questions

Common questions about Creutzfeldt Jacob disease

Creutzfeldt Jacob disease is a rare, transmittable disorder that affects the brain. It is caused by prions, which are unusual proteins that lead to brain damage. In this condition, the brain tissue gradually develops tiny holes, giving it a sponge-like appearance. This process is known as spongiform degeneration and affects important areas of the brain such as the cerebral and cerebellar cortex. People with this condition often experience changes in sleep patterns and personality, and may have difficulties with language (aphasia) and coordination (ataxia). The effects on the brain lead to other issues like muscle atrophy, weakness, poor vision, and involuntary jerking movements known as myoclonus. Unfortunately, the disease progresses quickly, and it typically leads to death within about a year from the start of symptoms.

Common symptoms of Creutzfeldt Jacob disease include sleep disturbances, changes in personality, problems with language such as aphasia, difficulties with balance and coordination (ataxia), muscle weakness and atrophy, visual problems, and sudden, uncontrollable movements called myoclonus.

The disease is caused by abnormal proteins called prions. These prions lead to the deterioration of brain tissue, resulting in the symptoms observed in this condition. There is no known genetic link or specific risk factor beyond the prion-related mechanism that causes the damage. Associated genes include PRNP.

← Back to All Diseases

gCJD	FFI	GSS
Dementia	95%	92%
Ataxia	100%	100%
Myoclonus	85%	92%
Extrapyramidal	65%	92%
Pyramidal	70%	71%
Visual/Cortical blindness	70%	85%
Dysarthria	Yes	Yes
Sleep disturbances	Yes	Yes
Weight loss	Yes	Yes

Research Type	Count	% of Total
Research summaries	33	26%
Patient case studies	31	25%
Laboratory research	22	18%
Disease patterns and progression	18	14%
Testing and diagnosis research	17	14%
Other research	3	2%
New treatment approaches	1	1%

Kisho

Creutzfeldt Jacob disease

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Clinical

Treatment

Management Guidelines

Evaluations Following Initial Diagnosis

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Laboratory

Differential Diagnosis

Treatment of Manifestations

Therapies Under Investigation

Clinical Trials

Recent Publications

Creutzfeldt Jacob disease

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Clinical

Treatment

Management Guidelines

Evaluations Following Initial Diagnosis

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

Subtypes

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is Creutzfeldt Jacob disease?

What are the symptoms of Creutzfeldt Jacob disease?

What causes Creutzfeldt Jacob disease?

How is Creutzfeldt Jacob disease diagnosed?

Are there treatments for Creutzfeldt Jacob disease?

What complications can arise from Creutzfeldt Jacob disease?

How does Creutzfeldt Jacob disease affect daily life?

What is the prognosis for someone with Creutzfeldt Jacob disease?

Are there any specialists recommended for managing Creutzfeldt Jacob disease?

Laboratory

Differential Diagnosis

Treatment of Manifestations

Therapies Under Investigation

Clinical Trials

Recent Publications